UGT1A1*6 and UGT1A1*28 polymorphisms are correlated with irinotecan-induced toxicity: A meta-analysis

作者: Yuwei Yang , MengMeng Zhou , Mingjun Hu , Yanjie Cui , Qi Zhong

DOI: 10.1111/AJCO.13028

关键词:

摘要: Background Previous articles explored the role of UGT1A1 polymorphism on predicting irinotecan-induced toxicity, but conclusions were still inconsistent and not comprehensive. We performed this meta-analysis to investigate association between toxicity. Methods PubMed Web Science searched for before July 2017. Inclusion exclusion criteria set select eligible articles, corresponding data extracted from those articles. Subgroup analyses based different cancer categories, doses races carried out achieve comprehensive results. Statistical conducted using STATA 11.0. Results A total 38 studies with 6742 cases included after reading full text. Both UGT1A1*6 UGT1A1*28 are significantly associated severe Asian Caucasian patients variant had an increased risk. Compared heterozygous variant, homozygous suffered a higher risk The effect diarrhea was less than neutropenia. analysis exhibited that polymorphism, treated low-dose irinotecan at notable Moreover, toxicity found in suffering respiratory system cancers. Conclusions polymorphisms can be considered as predictors varying by race, type dose.

参考文章(72)
Albert Font, José Miguel Sánchez, Miquel Tarón, Eva Martinez-Balibrea, José Javier Sánchez, José Luis Manzano, Mireia Margelí, Martin Richardet, Agustí Barnadas, Albert Abad, Rafael Rosell, Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism. Investigational New Drugs. ,vol. 21, pp. 435- 443 ,(2003) , 10.1023/A:1026251202137
Chonlaphat Sukasem, Chalirmporn Atasilp, Pichai Chansriwong, Montri Chamnanphon, Apichaya Puangpetch, Ekapob Sirachainan, Development of Pyrosequencing Method for Detection of UGT1A1 Polymorphisms in Thai Colorectal Cancers. Journal of Clinical Laboratory Analysis. ,vol. 30, pp. 84- 89 ,(2016) , 10.1002/JCLA.21820
Taroh Satoh, Takashi Ura, Yasuhide Yamada, Kentaro Yamazaki, Toshimasa Tsujinaka, Masaki Munakata, Tomohiro Nishina, Shu Okamura, Taito Esaki, Yasutsuna Sasaki, Wasaburo Koizumi, Yoshihiro Kakeji, Naoki Ishizuka, Ichinosuke Hyodo, Yuh Sakata, Genotype‐directed, dose‐finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms Cancer Science. ,vol. 102, pp. 1868- 1873 ,(2011) , 10.1111/J.1349-7006.2011.02030.X
Jing Gao, Jun Zhou, Yanyan Li, Zhi Peng, Yilin Li, Xicheng Wang, Lin Shen, Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients Medical Oncology. ,vol. 30, pp. 630- ,(2013) , 10.1007/S12032-013-0630-8
Federico Innocenti, Richard L. Schilsky, Jacqueline Ramírez, Linda Janisch, Samir Undevia, Larry K. House, Soma Das, Kehua Wu, Michelle Turcich, Robert Marsh, Theodore Karrison, Michael L. Maitland, Ravi Salgia, Mark J. Ratain, Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to the UGT1A1 Genotype of Patients With Cancer Journal of Clinical Oncology. ,vol. 32, pp. 2328- 2334 ,(2014) , 10.1200/JCO.2014.55.2307
Roberta Ferraldeschi, Laura J Minchell, Stephen A Roberts, Simon Tobi, Kristen D Hadfield, Fiona H Blackhall, Saifee Mullamitha, Gregory Wilson, Juan Valle, Mark Saunders, William G Newman, UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan Pharmacogenomics. ,vol. 10, pp. 733- 739 ,(2009) , 10.2217/PGS.09.20
X Liu, D Cheng, Q Kuang, G Liu, W Xu, None, Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians Pharmacogenomics Journal. ,vol. 14, pp. 120- 129 ,(2014) , 10.1038/TPJ.2013.10
Marie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Fabienne Thomas, Sylvie Quaranta, Nicolas Picard, Marie-Anne Loriot, Céline Narjoz, Delphine Poncet, Marie-Claude Gagnieu, Cécile Ged, Franck Broly, Valérie Le Morvan, Régis Bouquié, Marie-Pierre Gaub, Laurent Philibert, François Ghiringhelli, Chantal Le Guellec, , UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice Fundamental & Clinical Pharmacology. ,vol. 29, pp. 219- 237 ,(2015) , 10.1111/FCP.12117